May 28, 2022
Loading...
You are here:  Home  >  'ImmPACT Bio'
Latest

For ImmPact’s new CEO, Camarillo biotech company checked all the boxes

By   /  Friday, January 28th, 2022  /  Health Care & Life Science, Latest news, Subscriber content, Technology, Top Stories, Tri-County Economy, West Ventura County  /  Comments Off on For ImmPact’s new CEO, Camarillo biotech company checked all the boxes

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

New CEO, new board chair, new funding for ImmPact Bio

By   /  Thursday, January 20th, 2022  /  East Ventura County, Health Care & Life Science, Latest news, Startups, Technology, Top Stories, Tri-County Economy  /  Comments Off on New CEO, new board chair, new funding for ImmPact Bio

Camarillo-based ImmPact Bio made multiple headlines with one announcement on Jan. 20: the a new CEO, a new board chair, and the closing of a $111 million Series B funding round. ImmPact, a biotechnology company developing cancer treatments based on chimeric antigen receptor (CAR) T-cell therapies, named Sumant Ramachandra as its new president and CEO. Read More →

Latest

With merger, ImmPact Bio plans growth and a move to LA

By   /  Friday, July 30th, 2021  /  East Ventura County, Health Care & Life Science, Latest news, Subscriber content, Technology, Top Stories, Tri-County Economy, West Ventura County  /  Comments Off on With merger, ImmPact Bio plans growth and a move to LA

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Making an ImmPACT: New firm raises $18M to pursue T-cell therapies

By   /  Friday, August 28th, 2020  /  Health Care & Life Science, Latest news  /  Comments Off on Making an ImmPACT: New firm raises $18M to pursue T-cell therapies

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.